نتایج جستجو برای: β blockers
تعداد نتایج: 196219 فیلتر نتایج به سال:
P rimary percutaneous coronary intervention (PCI) is the preferred strategy of reperfusion for patients with ST-segment–elevation myocardial infarction (STEMI). With contemporary PCI techniques and adjunctive pharmacological therapy, primary PCI restores optimal epicardial flow in as many as 95% of patients with STEMI. 1 However despite remarkable improvement in the outcomes of patients with ST...
M e t h o d s Data sources: Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE/ Excerpta Medica, CINAHL, respiratory journals, meeting abstracts, and relevant references (up to May 2005). Study selection and assessment: Randomized, blinded, controlled trials (RCTs) in any language that evaluated cardioselective β-blockers as a single dose or for an extended period in patients with ...
4 Beta-adrenergic blocking agents or β-blockers are prescribed for the treatment of a broad array of common disorders. Their widespread use, coupled with a narrow therapeutic index, contributes to their being a significant cause of poisoning from overdose and the second most common cause of mortality from cardiovascular agents. This article provides an overview of beta-adrenergic system pathoph...
BACKGROUND It is unclear whether gender and racial/ethnic gaps in the use of and patient adherence to β-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and statins after acute myocardial infarction have persisted after establishment of the Medicare Part D prescription program. METHODS AND RESULTS This retrospective cohort study used 2007 to 2009 Medicare serv...
BACKGROUND AND OBJECTIVES Persons with kidney disease often have cardiovascular disease, but they are less likely to use recommended medications for secondary prevention. The hypothesis was that participants with reduced estimated GFR have lower use of medications recommended for secondary prevention of cardiovascular events (antiplatelet agents, angiotensin-converting enzyme inhibitors or angi...
AIMS Insulin resistance and the progressive loss of β-cell function are components of the fundamental pathophysiology of type II diabetes. A recent experimental study suggested that calcium channel blockers (CCBs) might inhibit β-cell apoptosis, enhance β-cell function, and prevent diabetes. The present meta-analysis examined the clinical effect of CCBs on the incidence of diabetes. METHODS M...
UNLABELLED Nonselective β-blockers are useful to prevent bleeding in patients with cirrhosis and large varices but not to prevent the development of varices in those with compensated cirrhosis and portal hypertension (PHT). This suggests that the evolutionary stage of PHT may influence the response to β-blockers. To characterize the hemodynamic profile of each stage of PHT in compensated cirrho...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید